Bumadizone calcium

This classification denotes a nonsteroidal antiinflammatory drug 4C19H21N2O3.2Ca.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7PSH384AJD, chemically known as calcium 2-(1,2-diphenylhydrazinocarbonyl)hexanoate hemihydrate, but more generally known as bumadizone calcium, which bears US NIH Compound Identifier 36833. European Medicines Agency schedules Bumadizone calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00896MIG. Most nations, for tariff and trade purposes, schedule bumadizone calcium under HS 29280090 and SITC 51486. As of Q4 2014, BUMADIZONE CALCIUM remains US FDA's Preferred Term for this commodity. SMILES: CCCCC(C(=O)N(C1CCCCC1)NC2CCCCC2)C(=O)[O-].CCCCC(C(=O)N(C1CCCCC1)NC2CCCCC2)C(=O)[O-].CCCCC(C(=O)N(C1CCCCC1)NC2CCCCC2)C(=O)[O-].CCCCC(C(=O)N(C1CCCCC1)NC2CCCCC2)C(=O)[O-].O.[CA+2].[CA+2].